Ariana Boswell

All articles by Ariana Boswell

• Rallybio to present latest data on potential FNAIT treatment

  Rallybio Corporation will present on March 4, 2025 at the TD Cowen 45th Annual Health Care Conference in Boston, MA.

• Rare Disease Day: Why it matters and how to get involved

  Rare Disease Day 2025 aims to uplift the rare disease community and promote greater awareness.

• Johnson & Johnson reports nipocalimab’s therapeutic potential in FNAIT

  Preclinical data published by Johnson & Johnson support the therapeutic promise of nipocalimab in IgG-driven diseases such as FNAIT.

• Review: Mechanisms of thrombocytopenia in children

  A recent study summarizes various types of thrombocytopenia, including FNAIT, detailing their causes, clinical presentations and treatments.

• First patient dosed in phase 2 study of potential FNAIT treatment

  The first patient has been dosed in a Phase 2 study that will test the efficacy of a monoclonal antibody in pregnant women at risk of FNAIT.

• Current guidelines for hematologic complications during pregnancy

  A recent review article describes the current guidelines for various hematological pregnancy complications including FNAIT.

• NICU program promotes collaboration between parents and staff

  A study found that NICUs that successfully implement a program encouraging family involvement see improvements in family-centered care.

• Careful ultrasound inspection key to detecting neonatal ICH

  While ultrasonography is often inferior to MRI in detecting cerebellar hemorrhage, increased scrutiny may improve detection rates.

• Noninvasive fetal blood test could aid in FNAIT diagnosis

  A new assay can help detect maternal-fetal incompatibilities in blood group and platelet antigens, which can lead to conditions such as FNAIT.

• Study calls for more research on blood donor clinical characteristics

  A recent literature review highlights the need for more research on blood donor characteristics and their impact on patient outcomes.